Enhancing natural killer cell-mediated lysis of lymphoma cells by combining therapeutic antibodies with CD20-specific immunoligands engaging NKG2D or NKp30
通过将治疗性抗体与结合NKG2D或NKp30的CD20特异性免疫配体联合使用，增强自然杀伤细胞介导的淋巴瘤细胞溶解作用
期刊:Oncoimmunology
影响因子:6.3
doi:10.1080/2162402X.2015.1058459
Kellner, Christian; Günther, Andreas; Humpe, Andreas; Repp, Roland; Klausz, Katja; Derer, Stefanie; Valerius, Thomas; Ritgen, Matthias; Brüggemann, Monika; van de Winkel, Jan Gj; Parren, Paul Whi; Kneba, Michael; Gramatzki, Martin; Peipp, Matthias
CD20
免疫/内分泌
CD2
自然杀伤细胞
淋巴瘤
细胞生物学
